Business Standard

Monday, December 23, 2024 | 06:30 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Neuland Labs zooms 20% on robust December quarter results

The stock is locked in upper circuit of 20 per cent at Rs 588 on the BSE after the company reported an over six-fold jump in net profit at Rs 4.6 crore in December 2018 quarter.

drugs
Premium

Photo: Shutterstock

SI Reporter Mumbai
Shares of Neuland Laboratories have locked in upper circuit of 20 per cent at Rs 588 apiece on the BSE after the company reported an over six-fold jumped in net profit at Rs 4.6 crore in December 2018 quarter (Q3FY19). The pharmaceutical company had a profit of Rs 0.74 lakh in the year-ago quarter.

Total revenue grew 40 per cent at Rs 172 crore against Rs 123 crore in the corresponding quarter of previous fiscal. Ebitda (earnings before interest, taxation, depreciation and amortisation) margin improved 100 basis points to 9.5 per cent from 8.5 per cent in the previous year quarter.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in